LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,865,000 | -0.5% | 5,000,000 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $4,887,000 | -2.6% | 5,000,000 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $5,016,000 | -0.3% | 5,000,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $5,032,000 | +1.8% | 5,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,941,000 | +58.9% | 5,000,000 | +66.7% | 0.00% | +33.3% |
| Q1 2021 | $3,110,000 | +8.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,872,000 | +5.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,727,000 | -92.5% | 3,000,000 | -92.9% | 0.00% | -92.9% |
| Q2 2020 | $36,493,000 | -39.9% | 41,980,000 | -42.6% | 0.04% | -48.1% |
| Q1 2020 | $60,706,000 | -29.5% | 73,090,000 | -26.2% | 0.08% | +2.5% |
| Q4 2019 | $86,106,000 | +4.0% | 99,090,000 | +0.5% | 0.08% | -2.5% |
| Q3 2019 | $82,764,000 | -1.2% | 98,640,000 | +1.5% | 0.08% | +3.8% |
| Q2 2019 | $83,789,000 | – | 97,140,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |